Lesaka Technologies, Inc. filed a Form 8-K on August 3, 2026, reporting that shareholders approved a stock option award of 1,000,000 share Options to Executive Chairman Ali Mazanderani at a special meeting held the same day.

Key Highlights

  • Option size: 1,000,000 share options to acquire common stock were granted to Executive Chairman Ali Mazanderani.
  • Exercise price: US$5.00 per share for all 1,000,000 options.
  • Vesting date: The Option Award vests on April 1, 2028, subject to continuous employment through that date.
  • Exercise window: Options may only be exercised after April 1, 2029, and expire on April 1, 2030.
  • No acceleration provisions: The filing states there is no acceleration of vesting upon termination, death, disability, or a change in control.
  • Shareholder vote: The proposal received 38,334,363 votes for, 1,241,298 against, and 7,796,947 abstentions.
  • Clawback applies: The Option Award is subject to the company's clawback policy, as in effect from time to time.

Lesaka Shareholder Vote Approves Mazanderani Option Award Terms

According to the filing, shareholders of Lesaka Technologies, Inc. ( Nasdaq : LSAK) approved the grant at a special meeting held on August 3, 2026. The approval was sought to comply with Nasdaq Listing Rule 5635(c), as described in the company's definitive proxy statement filed with the Securities and Exchange Commission on July 2, 2026. The Board had previously approved the Option Award subject to shareholder ratification.

The filing discloses that Mr. Mazanderani may exercise vested options only after April 1, 2029, with the award expiring on April 1, 2030. Vesting is contingent solely on continuous employment through April 1, 2028. The filing explicitly states that there is no automatic acceleration of vesting upon termination of employment, death, disability, or a change in control of the company. The Option Award is also stated to be subject to the company's clawback policy as in effect from time to time.

The filing outlines several permitted exercise methods, including cash payment, offset against amounts owed by the company to Mr. Mazanderani, tender of stock held by Mr. Mazanderani, broker-assisted cashless exercise, net exercise pursuant to an agreed formula in the Option Agreement, any other means acceptable to the company, or a combination of the foregoing. The full text of the Option Award was included as Appendix A to the 2026 Proxy Statement and is attached as Exhibit 10.1 to the Form 8-K. The filing was signed by Dan Smith, Group Chief Financial Officer.

What Was Disclosed

The Form 8-K reported shareholder approval of a 1,000,000 share option grant to Executive Chairman Ali Mazanderani, including full award terms, exercise conditions, vesting schedule, and the voting results from the August 3, 2026 special meeting.